Holen Sie sich die Stockscreener-App
2.355
3.48%
-0.085
Schlusskurs vom Vortag:
$2.44
Offen:
$2.4
24-Stunden-Volumen:
67,006
Relative Volume:
0.18
Marktkapitalisierung:
$52.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.51M
KGV:
-1.7408
EPS:
-1.3528
Netto-Cashflow:
$-15.68M
1W Leistung:
-1.46%
1M Leistung:
-7.28%
6M Leistung:
-46.60%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.30
$2.451
1-Wochen-Bereich:
$2.30
$2.5999
52-Wochen-Spanne:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Firmenname
Medicus Pharma Ltd
Sektor
Telefon
610-540-7515
Adresse
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Vergleichen Sie MDCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.35 | 52.35M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
877.46 | 772.28B | 59.42B | 18.41B | -50.20M | 20.22 |
|
JNJ
Johnson Johnson
|
188.59 | 455.04B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
215.81 | 385.18B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
123.44 | 237.53B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
84.25 | 214.76B | 63.99B | 19.05B | 14.72B | 7.5596 |
Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten
How strong is Medicus Pharma Ltd. Equity Warrant stock revenue growthWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Applying Elliott Wave Theory to Medicus Pharma Ltd. Equity Warrant2025 Performance Recap & Entry Point Strategy Guides - newser.com
How Medicus Pharma Ltd. (N460) stock behaves under inflation pressure2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
What risks investors should watch in Medicus Pharma Ltd. Equity Warrant stockPortfolio Return Summary & Risk Controlled Stock Pick Alerts - newser.com
What drives Medicus Pharma Ltd Equity Warrant stock priceMarket Entry Points & Affordable Trading Techniques - earlytimes.in
Why Medicus Pharma Ltd. (N460) stock could be top winnerTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Courier & Press
Technical signs of recovery in Medicus Pharma Ltd.2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Chart based exit strategy for Medicus Pharma Ltd. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - newser.com
How Medicus Pharma Ltd. (N460) stock reacts to monetary easingTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Medicus Pharma eyes compassionate use approval of Skinject for Gorlin SyndromeICYMI - Proactive financial news
Why Medicus Pharma Ltd. Equity Warrant stock is favored by pension funds2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock a safe buy before earningsJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
What MACD and RSI say about Medicus Pharma Ltd.Weekly Stock Summary & Consistent Income Trade Recommendations - newser.com
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - The Holland Sentinel
Technical analysis overview for Medicus Pharma Ltd. Equity Warrant stockMarket Risk Analysis & AI Driven Price Predictions - newser.com
How resilient is Medicus Pharma Ltd. Equity Warrant stock in market downturns2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Real time breakdown of Medicus Pharma Ltd. stock performanceDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosMarket Trend Report & Community Verified Watchlist Alerts - newser.com
Medicus Pharma Ltd. stock trendline breakdown2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Medicus Pharma Ltd. Equity Warrant stock momentum explainedJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock supported by innovation pipelineAnalyst Downgrade & Free High Return Stock Watch Alerts - newser.com
Should you wait for a breakout in Medicus Pharma Ltd.July 2025 Outlook & Free Safe Capital Growth Stock Tips - newser.com
How Medicus Pharma Ltd. Equity Warrant stock benefits from global expansion2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Why Medicus Pharma Ltd. (N460) stock fits value portfolios2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Can Medicus Pharma Ltd. Equity Warrant stock resist market sell offsOptions Play & Verified Swing Trading Watchlist - newser.com
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - Chambersburg Public Opinion
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Holland Sentinel
Medicus Pharma Ltd’s Strategic Collaboration and Promising Phase 2 Results Justify Buy Rating - TipRanks
Medicus Pharma partners with Gorlin Syndrome Alliance to expand compassionate access to SKINJECT - Proactive financial news
Medicus Pharma Collaborates with Gorlin Syndrome Alliance for SKINJECT™ Access - MSN
Is Medicus Pharma Ltd. Equity Warrant stock reversal real or fake2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Can Medicus Pharma Ltd. stock deliver consistent earnings growthJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What momentum indicators show for Medicus Pharma Ltd. stockJuly 2025 Market Mood & Low Drawdown Investment Strategies - newser.com
Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):